Values First Advisors’s Aura Biosciences AURA Stock Holding History

Values First Advisors’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,195	Closed	-$153K	–	230
2024 Q3	$153K	Sell	17,195 -929	-5%	-$7.97K	0.08%	163
2024 Q2	$137K	Sell	18,124 -9,167	-34%	-$67.1K	0.08%	151
2024 Q1	$214K	Buy	27,291 +16,362	+150%	+$136K	0.13%	146
2023 Q4	$96.8K	Buy	10,929 +528	+5%	+$4.47K	0.06%	153
2023 Q3	$93.3K	Buy	10,401 +217	+2%	+$2.33K	0.06%	150
2023 Q2	$126K	Buy	10,184 +4,282	+73%	+$45.8K	0.08%	154
2023 Q1	$54.8K	Buy	+5,902	New	+$61.3K	0.03%	187

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Values First Advisors's AURA Position: Q4 2024 in Review

Values First Advisors sold out of Aura Biosciences (AURA) in Q4 2024, closing a stake of 17,195 shares — an estimated $153K sold.

Values First Advisors first reported a position in AURA in Q1 2023 and held it in 7 quarters. The position peaked at $214K in Q1 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q4 2024.

Values First Advisors reported no remaining Aura Biosciences position as of Q4 2024 after selling out during the quarter.
Values First Advisors sold 17,195 Aura Biosciences shares in Q4 2024, an estimated $153K.
Values First Advisors first reported a position in Aura Biosciences in Q1 2023 and held it in 7 quarters.
Values First Advisors's Aura Biosciences position peaked at $214K in Q1 2024.
94 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2024.

Based on Values First Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.